000 01427 a2200409 4500
005 20250515165814.0
264 0 _c20090623
008 200906s 0 0 eng d
022 _a1878-0261
024 7 _a10.1016/j.molonc.2007.10.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCardoso, Fatima
245 0 0 _aThe MINDACT trial: the first prospective clinical validation of a genomic tool.
_h[electronic resource]
260 _bMolecular oncology
_cDec 2007
300 _a246-51 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aClinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aGene Expression Profiling
650 0 4 _aGenomics
_xinstrumentation
650 0 4 _aHumans
650 0 4 _aMulticenter Studies as Topic
650 0 4 _aMutation
650 0 4 _aOligonucleotide Array Sequence Analysis
650 0 4 _aPrognosis
650 0 4 _aProspective Studies
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aReproducibility of Results
650 0 4 _aResearch Design
700 1 _aPiccart-Gebhart, Martine
700 1 _aVan't Veer, Laura
700 1 _aRutgers, Emiel
773 0 _tMolecular oncology
_gvol. 1
_gno. 3
_gp. 246-51
856 4 0 _uhttps://doi.org/10.1016/j.molonc.2007.10.004
_zAvailable from publisher's website
999 _c18814447
_d18814447